IL4 and pancreatic ductal adenocarcinoma: In a large cohort of patients with pancreatic ductal adenocarcinoma (PDAC), basophils expressing interleukin-4 (IL-4) were identified in the tumor-draining lymph nodes (TDLN; the main sites of antitumor immunity development).